Cyclophilin A is required for M-CSF-dependent macrophage proliferation

European Journal of Immunology

Volumn 36, Issue 9, 2006, Pages 2515-2524

  Sànchez Tilló, Ester ^a   Wojciechowska, Marta ^a   Comalada, Monica ^a   Farrera, Consol ^a   Lloberas, Jorge ^a   Celada, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Macrophages; Phosphatases; Proliferation; Protein kinases; Signal transduction

Indexed keywords

COLONY STIMULATING FACTOR 1; CYCLIN DEPENDENT KINASE 2; CYCLOPHILIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MYC PROTEIN; PROTEASOME; RAF PROTEIN; SANGLIFEHRIN A;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLOPHILIN A; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; G1 PHASE; LACTONES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENE PROTEINS C-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPIRO COMPOUNDS;

EID: 33748859021     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535270     Document Type: Article

References (59)

1. Sanglier, J. J., Quesniaux, V., Fehr, T., Hofmann, H., Mahnke, M., Memmert, K, Schuler, W. et al., Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity. J. Antibiot. (Tokyo) 1999. 52: 466-473.
2. Fehr, T., Katlen, J., Oberer, L., Sanglier, J. J. and Schilling, W., Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties. J. Antibiot. (Tokyo) 1999. 52: 474-479.
3. Zenke, G., Strittmatter, U., Fuchs, S., Quesniaux, V. F., Brinkmann, V., Schuler, W., Zurini, M. et al., Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action. J. Immunol. 2001. 166: 7165-7171.
4. Bierer, B. E., Hollander, G., Fruman, D.and Burakoff, S. J., Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr, Opin, Immunol, 1993. 5: 763-773.
5. Abraham, R. T. and Wiederrecht, G. J., Immunopharmacology of rapamycin. Annu, Rev, Immunol, 1996. 14: 483-510.
6. Rowinsky, E. K., Targeting the molecular target of rapamycin (mTOR). Curr. Opin. Oncol. 2004. 16: 564-575.
7. Allen, A., Zheng, Y., Gardner, L., Safford, M., Horton, M. R. and Powell, J. D., The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J. Immunol. 2004. 172: 4797-4803.
8. Zhang, L. H., Youn, H. D. and Liu, J. O., Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53. J. Biol. Chem. 2001. 276: 43534-43540.
9. Comalada, M., Valledor, A. F., Sanchez-Tillo, E., Umbert, I., Xaus, J.and Celada, A., Macrophage colony-stimulating factor-dependent macrophage proliferation is mediated through a calcineurin-independent but immunophilin-dependent mechanism that mediates the activation of external regulated kinases. Eur. J. Immunol. 2003. 33: 3091-3100.
10. Zhang, L. H.and Liu, J. O., Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle. J. Immunol. 2001. 166: 5611-5618.
11. Stanley, E. R., Berg, K. L., Einstein, D. B., Lee, P. S., Pixley, F. J., Wang, Y. and Yeung, Y. G., Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 1997 46: 4-10.
12. McKnight, A. J., Macfarlane, A. J., Dri, P., Turley, L., Willis, A. C. and Gordon, S., Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J. Biol. Chem. 1996. 271: 486-489.
13. Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A. and Tenen, D. G., The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol. Chem. 1993. 268: 5014-5020.
14. Xaus, J., Cardo, M., Valledor, A. F., Soler, C., Lloberas, J. and Celada, A., Interferon gamma induces the expression of p2lwaf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 1999. 11: 103-113.
15. Kalitsis, P., Earle, E., Fowler, K. J. and Choo, K. H., Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev. 2000. 14: 2277-2282.
16. Begg, A. C., McNally, N. J., Shrieve, D. C. and Karcher, H., A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985. 6: 620-626.
17. Amati, B., Alevizopoulos, K. and Vlach, J., Myc and the cell cycle. Front Biosci. 1998. 3: d250-268.
18. Servant, M. J., Coulombe, P., Turgeon, B. and Meloche, S., Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J. Cell. Biol. 2000. 148: 543-556.
19. Medema, R. H., Kops, G. J., Bos, J. L. and Burgering, B. M., AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000. 404: 782-787.
20. Kamiyama, J., Inoue, T., Ohtani-Fujita, N., Minami, S., Yamagishi, H. and Sakai, T., The ubiquitous transcription factor NF-Y positively regulates the transcription of human p27Kip1 through a CCAAT box located in the 5-upstream region of the p27Kip1 gene. FEBS Lett. 1999. 455: 281-285.
21. Meyer, S., Kohler, N. G. and Joly, A., Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett. 1997. 413: 354-358.
22. Sanchez-Tillo, E., Comalada, M., Farrera, C., Valledor, A. F., Lloberas, J. and Celada, A., Macrophage-colony-stimudating factor-induced proliferation and lipopolysaccharide-dependent activation of macrophages requires raf-1 phosphorylation to induce mitogen kinase phosphatase-1 expression. J. Immunol. 2006. 176: 6594-6602.
23. Valledor, A. F., Xaus, J., Comalada, M., Soler, C. and Celada, A., Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 2000. 164: 29-37.
24. Valledor, A. F., Comalada, M., Xaus, J. and Celada, A., The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 2000. 275: 7403-7409.
25. Valledor, A. F., Xaus, J., Marques, L. and Celada, A., Macrophage colony-stimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. J. Immunol. 1999. 163: 2452-2462.
26. Comalada, M., Xaus, J., Sanchez, E., Valledor, A. F. and Celada, A., Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway. Eur. J. Immunol. 2004. 34: 2257-2267.
27. Pardee, A. B., G1 events and regulation of cell proliferation. Science 1989. 246: 603-608.
28. Matsushime, H., Roussel, M. F., Ashmun, R. A. and Sherr, C. J., Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991. 65: 701-713.
29. Mateyak, M. K., Obaya, A. J. and Sedivy, J. M., c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 1999. 19: 4672-4683.
30. Obaya, A. J., Kotenko, L, Cole, M. D. and Sedivy, J. M., The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. J. Biol. Chem. 2002. 277: 31263-31269.
31. Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D. and Amati, B., Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 1996. 15: 6595-6604.
32. Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A. and Pagano, M., Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 1999. 13: 1181-1189.
33. Shirane, M., Harumiya, Y., Ishida, N., Hirai, A., Miyamoto, C., Hatakeyama, S., Nakayama, K. and Kitagawa, M., Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol. Chem. 1999. 274: 13886-13893.
34. Carrano, A. C., Eytan, E., Hershka, A. and Pagano, M., SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell. Biol. 1999. 1: 193-199.
35. Boehm, M., Yoshimoto, T., Crook, M. F., Nallamshetty, S., True, A., Nabel, G. J. and Nabel, E. G., A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 2002. 21: 3390-3401.
36. Berns, K., Hijmans, E. M. and Bernards, R., Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 1997. 15: 1347-1356.
37. Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H. and Okayama, H., Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 1994. 13: 1549-1556.
38. Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J. and Sherr, C. J., Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 1994. 79: 487-496.
39. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J. et al., Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994. 372: 570-573.
40. Matsuoka, M., Nishimoto, I. and Asano, S., Interferon-gamma impairs physiologic downregulation of cyclin-dependent kinase inhibitor, p27Kip1, during G1 phase progression in macrophages. Exp. Hematol. 1999. 27: 203-209.
41. Kuniyasu, H., Yasui, W., Kitahara, K., Naka, K., Yokozaki, H., Akama, Y., Hamamoto, T. et al., Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Cell Growth Differ. 1997. 8: 47-52.
42. Kortylewski, M., Heinrich, P. C., Mackiewicz, A., Schniertshauer, U., Klingmuller, U., Nakajima, K., Hirano, T. et al., Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene 1999. 18: 3742-3753.
43. Alessandrini, A., Chiaur, D. S. and Pagano, M., Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 1997. 11: 342-345.
44. Cheng, M., Sexl, V., Sherr, C. J. and Roussel, M. F., Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 1998. 95: 1091-1096.
45. Liang, J. and Slingerland, J. M., Multiple roles of the P13 K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003. 2: 339-345.
46. Collado, M., Medema, R. H., Garcia-Cao, I., Dubuisson, M. L., Barradas, M., Glassford, J., Rivas, C. et al., Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J. Biol. Chem. 2000. 275: 21960-21968.
47. Xaus, J., Comalada, M., Cardo, M., Valledor, A. F. and Celada, A., Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21 (Waf1). Blood 2001. 98: 2124-2133.
48. Brondello, J. M., Brunet, A., Pouyssegur, J. and McKenzie, F. R., The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 1997.272: 1368-1376.
49. Coss, M. C., Stephens, R. M., Morrison, D. K., Winterstein, D., Smith, L.M. and Simek, S. L., The immunophilin FKBP65 forms an association with the serine/threonine kinase c-Raf-1. Cell Growth Differ. 1998. 9: 41-48.
50. Stancato, L. F., Chow, Y. H., Owens-Grillo, J. K., Yem, A. W., Deibel, M. R., Jr., Jove, R. and Pratt, W. B., The native v-Raf.hsp90.p5O heterocomplex contains a novel immunophilin of the FK506 binding class. J. Biol. Chem. 1994. 269: 22157-22161.
51. Krautwald, S., Buscher, D., Dent, P., Ruthenberg, K. and Baccarini, M., Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase. Oncogene 1995. 10: 1187-1192.
52. Cheng, J. J., Wung, B. S., Chao, Y. J. and Wang, D. L., Sequential activation of protein kinase C (PKC)-alpha and PKC-epsilon contributes to sustained Raf/ERK1/2 activation in endothelial cells under mechanical strain. J. Biol. Chem. 2001. 276: 31368-31375.
53. Cai, H., Smola, U., Wixler, V., Eisenmann-Tappe, I., Diaz-Meco, M. T., Moscat, J., Rapp, U. and Cooper, G. M., Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell. Biol. 1997. 17: 732-741.
54. Celada, A., Gray, P. W., Rinderknecht, E. and Schreiber, R. D., Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 1984. 160: 55-74.
55. Herrero, C., Marques, L., Lloberas, J. and Celada, A., IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J. Clin. Invest. 2001. 107: 485-493.
56. Celada, A. and Maki, R. A., Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages. J. Immunol. 1992. 148: 1102-1105.
57. Caelles, C., Gonzalez-Sancho, J. M. and Munoz, A., Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 1997. 11: 3351-3364.
58. Torczynski, R., Bollon, A. P. and Fuke, M., The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes. Nucleic Acids Res. 1983. 11: 4879-4890.
59. Marques, L., Brucet, M., Lloberas, J. and Celada, A., STAT1 regulates lipopolysaccharicle- and TNF-alpha-dependent expression of transporter associated with antigen processing 1 and low molecular mass polypeptide 2 genes in macrophages by distinct mechanisms. J. Immunol. 2004. 173: 1103-1110.